Additional file 2 of Fragment length profiles of cancer mutations enhance detection of circulating tumor DNA in patients with early-stage hepatocellular carcinoma

Additional file 2: Table S1A. Clinical characteristics of patients and healthy controls in the discovery cohort. Table S1B. Clinical characteristics of patients and healthy controls in the validation cohort. Table S2. Gene panel for targeted sequencing. Table S3. Frequencies of mutations of difference sources in 55 HCC patients.